Microsatellite Instability Testing The latest news on microsatellite instability testing. Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer The assay is intended to detect Dana Farber Team Applies PCR Method to ID Microsatellite Instability in Tumor-Derived Samples Premium The group aims to adapt the method, which detects poly-adenine tails, to monitor for minimal residual disease in late-stage colon cancer patients after surgery. Researchers Aim to Improve Lynch Syndrome Testing With Genetic-Epigenetic Combination Method Premium The sequencing test involves a single library preparation that is then split for parallel analysis of promoter methylation, MSI calculation, and gene mutation detection. Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions. Disparity in Microsatellite Instability Testing Suggests Need to Close Socioeconomic Access Gaps Premium Researchers are continuing to collect data on economic, racial, and other factors that could be addressed to make precision medicine access more equitable. Sep 22, 2020 Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug Jul 21, 2020 NCCN's Updated Inherited Colorectal Cancer Risk Guidelines Features Gene-Specific Information Jun 9, 2020 Promega Nabs CE Mark for Microsatellite Instability IVD May 5, 2020 Bayer, NeoGenomics Launch Free NTRK Fusion Testing Program Apr 14, 2020 Merck Bid for Second Pan-Cancer Keytruda Indication Would Raise Tumor Mutation Burden to CDx Status Premium Mar 5, 2020 Biocartis Reports 35 Percent 2019 Revenue Rise, New Bristol-Myers Squibb CDx Project Feb 19, 2020 Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing Feb 12, 2020 Exact Sciences Boosting Position in Cancer Dx Market Through M&A Premium Jan 27, 2020 Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers Premium Dec 17, 2019 NeoGenomics Focused on Companion Diagnostics, NGS in 2020 Premium Nov 7, 2019 Colorectal Cancers Dial up Mutability in Response to Targeted Treatments Nov 6, 2019 Merck, Promega Collaborate to Develop MSI CDx for Keytruda Oct 24, 2019 Calviri to Develop Checkpoint Inhibitor Response Prediction Test Under $300K NCI Grant Sep 23, 2019 PGDx Shares New MSI Data, Provides Update on FDA Bid for Pan-Cancer IVDs Premium Aug 8, 2019 Guardant Health Preps Pan-Cancer FDA Bid, Highlights New MSI Validation Data Premium May 16, 2019 NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy Premium May 2, 2019 Liquid Biopsy-Based Androgen Receptor Alterations Associated With Advanced Prostate Cancer Outcomes Apr 9, 2019 Immunotherapy Developers, Clinical Researchers Continue to Seek New Dx Strategies Premium Mar 5, 2019 Biocartis Pushing Further Into Immunotherapy, Liquid Biopsy Space With Idylla Menu Premium Feb 28, 2019 Biocartis 2018 Revenues Rise 32 Percent Load More Breaking News Bruker Posts 34 Percent Jump in Q2 Revenues GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases Feinstein Institutes for Medical Research Wins $2.9M NIH Grant to Study Polygenic Embryo Screening Top Five Articles on GenomeWeb Last Week: CDC, Bio-Rad, 10x Genomics, PerkinElmer, and More InterVenn Biosciences Closes $201M Series C Round Abcam to Acquire Life Science Research Tool Firm BioVision for $340M The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.